GHAP Medical and Aesthetic Awards 2020 | Page 44

MEDICAL

FERTILITY MEDICAL CENTRE OF THE YEAR IN THE ASIA-PACIFIC

VIRTUS FERTILITY
Virtus Fertility Centre Singapore ( VFCS ) began operations in January 2015 in a purpose-built , dedicated in vitro fertilisation ( IVF ) facility together with a team of passionate fertility specialists , embryologists , and specially trained nurses with a vision to improve outcomes for its patients .
VFCS is one of the centres in Virtus Health , an Australian company and the fourth largest provider of IVF services globally , and its mission is to provide personal fertility services enhanced by the passion of people and the precision of technology by creating a culture with the ambition to continually deliver the best care , science , and outcome .
VFCS is proud to have a unique ‘ clean room ’ embryology laboratory and automated radio-frequency identification , thereby providing optimal safety , service quality assurance , and peace of mind for its patients .
The IVF centre is easily accessible by patients and providers alike as it is located along Scotts Road , which is a walking distance from the famous Singapore Orchard Road shopping and entertainment area , while still giving its clientele a sense of privacy once they enter the centre .
The clinical team works closely with a group of dedicated fertility coaches to help couples cope with stress as they undergo IVF . The positivity and calm assurance that they are not alone help to pave the way for smoother cycles and better outcomes .
The team at VFCS strives to improve clinical outcomes by regularly reviewing performance within and
Cassie Leong and Stephanie Chan
without the Virtus Health group of IVF centres and adopting the latest technologies and knowledge in IVF .
In 2018 , it achieved an overall clinical pregnancy rate per transfer of 58 percent and a cumulative clinical pregnancy rate per egg retrieval of 71 percent . It also achieved an overall live birth rate per egg retrieval , resulting in a frozen transfer of 57 percent and 54 percent in 2017 and 2018 respectively . The majority of its patients lie within the band of 35 to 45 years of age .
VFCS combines high magnification technology that can identify and select sperm with good DNA integrity with intra-cytoplasmic sperm injection ( ICSI ) to improve embryo quality and pregnancy outcomes . In addition , VFCS also employs Polarised
Light Microscopy ( PLM ) to identify healthy eggs for fertilisation . This is particularly useful for more mature patients where genetic abnormalities are more common and eggs are fewer . The premise is to ‘ Make Every Egg Count ’ and use innovation to better understand a patient ’ s egg quality , thereby optimising outcomes . Sperm analysis has always been emphasised at VCFS as well , and equal care is taken to select each sperm for the ICSI process .
To optimise workflow and minimise the exposure of the embryos by frequent assessment , VFCS uses the time-lapse incubation system which allows the process of embryo development to be continually monitored without disrupting their environment . This process is further enhanced by using artificial intelligence and visual assessments to help determine which embryos are more likely to succeed in producing a viable pregnancy .
In 2021 , VFCS is expanding its clinical capacity to better serve patients and providers . It remains committed to serving its patients with empathy and a mindset of excellence in every step of their journey to help them optimise their own potential to achieve their goal of becoming parents .
VFCS is committed and continues to work with its colleagues within the Virtus Health group of IVF centres and other IVF centres to support patients ’ various needs .
42 2020 AWARDS SPECIAL GlobalHealthAsiaPacific . com